Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting tyrosine kinase pathways involved in cancer cell proliferation. Shows potential in the development of antitumor agents due to its ability to modulate signaling pathways in malignant cells. Also employed in the design of selective enzyme inhibitors for inflammatory and neurodegenerative diseases. Its structure supports high binding affinity to specific protein targets, making it valuable in structure-activity relationship (SAR) studies during drug optimization.